209 related articles for article (PubMed ID: 15140032)
1. HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease.
Margaritte-Jeannin P; Babron MC; Bourgey M; Louka AS; Clot F; Percopo S; Coto I; Hugot JP; Ascher H; Sollid LM; Greco L; Clerget-Darpoux F
Tissue Antigens; 2004 Jun; 63(6):562-7. PubMed ID: 15140032
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.
Laivoranta-Nyman S; Möttönen T; Hermann R; Tuokko J; Luukkainen R; Hakala M; Hannonen P; Korpela M; Yli-Kerttula U; Toivanen A; Ilonen J;
Ann Rheum Dis; 2004 Nov; 63(11):1406-12. PubMed ID: 15479890
[TBL] [Abstract][Full Text] [Related]
3. Modifying effect of HLA haplotypes located trans to DQB1*02-DRB1*03 in celiac patients of Southern Europe.
Hernández-Charro B; Donat E; Miner I; Aranburu E; Sánchez-Valverde F; Ramos-Arroyo MA
Tissue Antigens; 2008 Mar; 71(3):213-8. PubMed ID: 18257894
[TBL] [Abstract][Full Text] [Related]
4. Defining the contribution of the HLA region to cis DQ2-positive coeliac disease patients.
van Belzen MJ; Koeleman BP; Crusius JB; Meijer JW; Bardoel AF; Pearson PL; Sandkuijl LA; Houwen RH; Wijmenga C
Genes Immun; 2004 May; 5(3):215-20. PubMed ID: 15014431
[TBL] [Abstract][Full Text] [Related]
5. Allele and haplotype frequencies for HLA class II (DQA1 and DQB1) loci in patients with celiac disease from Spain.
Vidales MC; Zubillaga P; Zubillaga I; Alfonso-Sánchez MA
Hum Immunol; 2004 Apr; 65(4):352-8. PubMed ID: 15120190
[TBL] [Abstract][Full Text] [Related]
6. Screening of coeliac disease in north Italian children with type 1 diabetes: limited usefulness of HLA-DQ typing.
Contreas G; Valletta E; Ulmi D; Cantoni S; Pinelli L
Acta Paediatr; 2004 May; 93(5):628-32. PubMed ID: 15174785
[TBL] [Abstract][Full Text] [Related]
7. Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both.
Dezsofi A; Szebeni B; Hermann CS; Kapitány A; Veres G; Sipka S; Körner A; Madácsy L; Korponay-Szabó I; Rajczy K; Arató A
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):283-7. PubMed ID: 18728522
[TBL] [Abstract][Full Text] [Related]
8. HLA-DQ and susceptibility to celiac disease: evidence for gender differences and parent-of-origin effects.
Megiorni F; Mora B; Bonamico M; Barbato M; Montuori M; Viola F; Trabace S; Mazzilli MC
Am J Gastroenterol; 2008 Apr; 103(4):997-1003. PubMed ID: 18177450
[TBL] [Abstract][Full Text] [Related]
9. HLA class II DR and DQ genotypes and haplotypes associated with rheumatic fever among a clinically homogeneous patient population of Latvian children.
Stanevicha V; Eglite J; Zavadska D; Sochnevs A; Shantere R; Gardovska D
Arthritis Res Ther; 2007; 9(3):R58. PubMed ID: 17559688
[TBL] [Abstract][Full Text] [Related]
10. HLA-DQA1*0501 and DQB1*02 homozygosity and disease susceptibility in Spanish coeliac patients.
Arranz E; Telleria JJ; Sanz A; Martin JF; Alonso M; Calvo C; Blanco-Quirós A
Exp Clin Immunogenet; 1997; 14(4):286-90. PubMed ID: 9523165
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect.
Vermeulen BA; Hogen Esch CE; Yuksel Z; Koning F; Verduijn W; Doxiadis II; Schreuder GM; Mearin ML
Scand J Gastroenterol; 2009; 44(1):40-5. PubMed ID: 18932050
[TBL] [Abstract][Full Text] [Related]
12. HLA genotyping is useful in the evaluation of the risk for coeliac disease in the 1st-degree relatives of patients with coeliac disease.
Karinen H; Kärkkäinen P; Pihlajamäki J; Janatuinen E; Heikkinen M; Julkunen R; Kosma VM; Naukkarinen A; Laakso M
Scand J Gastroenterol; 2006 Nov; 41(11):1299-304. PubMed ID: 17060123
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312
[TBL] [Abstract][Full Text] [Related]
14. High risk genotypes for celiac disease.
Clerget-Darpoux F; Bouguerra F; Kastally R; Semana G; Babron MC; Debbabi A; Bennaceur B; Eliaou JF
C R Acad Sci III; 1994 Oct; 317(10):931-6. PubMed ID: 7882136
[TBL] [Abstract][Full Text] [Related]
15. High frequency of low-risk human leukocyte antigen class II genotypes in latent celiac disease.
Schirru E; Jores RD; Cicotto L; Frau F; De Virgiliis S; Rossino R; Macis MD; Lampis R; Congia M
Hum Immunol; 2011 Feb; 72(2):179-82. PubMed ID: 21075156
[TBL] [Abstract][Full Text] [Related]
16. Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles.
Pietzak MM; Schofield TC; McGinniss MJ; Nakamura RM
Clin Gastroenterol Hepatol; 2009 Sep; 7(9):966-71. PubMed ID: 19500688
[TBL] [Abstract][Full Text] [Related]
17. [Gluten enteropathy in Croatian children is primarily associated with the HLA-DR3-DQ2 haplotype].
Jurcić Z; Brkljacić-Surkalović L; Grubić Z; Zunec R; Vezmar V; Kastelan A
Lijec Vjesn; 2000; 122(11-12):259-63. PubMed ID: 11291267
[TBL] [Abstract][Full Text] [Related]
18. Gene dose effect of the DQB1*0201 allele contributes to severity of coeliac disease.
Karinen H; Kärkkäinen P; Pihlajamäki J; Janatuinen E; Heikkinen M; Julkunen R; Kosma VM; Naukkarinen A; Laakso M
Scand J Gastroenterol; 2006 Feb; 41(2):191-9. PubMed ID: 16484124
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of two HLA heterodimers in the susceptibility to celiac disease in Tunisia.
Bouguerra F; Babron MC; Eliaou JF; Debbabi A; Clot J; Khaldi F; Greco L; Clerget-Darpoux F
Genet Epidemiol; 1997; 14(4):413-22. PubMed ID: 9271713
[TBL] [Abstract][Full Text] [Related]
20. HLA in coeliac disease families: a novel test of risk modification by the 'other' haplotype when at least one DQA1*05-DQB1*02 haplotype is carried.
Louka AS; Nilsson S; Olsson M; Talseth B; Lie BA; Ek J; Gudjónsdóttir AH; Ascher H; Sollid LM
Tissue Antigens; 2002 Aug; 60(2):147-54. PubMed ID: 12392509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
